MYX 0.62% $4.78 mayne pharma group limited

Congratulations Mithra, page-7

  1. 1,125 Posts.
    lightbulb Created with Sketch. 326
    It does Charts. Massive gamble on unknown
    sales of unapproved products with unknown/
    ambiguous efficacy and unknown time frames.
    We can punch in the numbers on a calculator
    but cannot sell an unapproved product to the
    market. The language on E4 was extremely
    wishy washy ambiguous sales pitch stuff that
    hasn’t Impressed the market. This buys.....
    Richards more time in the top job, and thus
    far as a chronic under performer who has been
    handsomely remunerated over the years for
    destruction of share holder value. He hasn’t
    a great track record on his own personal finances either
    given he apparently copped a margin call and
    had to off load a pile of his MYX shares knowing
    that he’s going to keep getting allocated more.
    Simply Wall Street suggests he’s at the high end
    of remuneration for a company size/value such as
    MYX.
    No wonder the market is concerned.
    It’s like watching a talent scout recruiting
    a striker who can’t kick goals. After a while the
    members start asking questions about the recruiter
    who keeps presiding over poor decision making. I
    can understand 5% but 10% on a promise of big
    profits in the future is a massive gamble.
    This gamble has to pay off there’s no two ways
    about it. Can’t see MYX doing anything other
    than languishing now over the foreseeable future
    but I hope to be proven wrong and plan to continue
    to hold in hope

 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.78
Change
-0.030(0.62%)
Mkt cap ! $406.6M
Open High Low Value Volume
$4.84 $4.84 $4.63 $435.1K 91.84K

Buyers (Bids)

No. Vol. Price($)
1 746 $4.74
 

Sellers (Offers)

Price($) Vol. No.
$4.78 1776 2
View Market Depth
Last trade - 16.10pm 10/09/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.